In the news release, “WuXi PharmaTech Schedules Fourth Quarter 2008 Earnings Release on Thursday, March 26, 2009,” issued on March 12 by WuXi PharmaTech (Cayman) Inc. over PR Newswire Asia, we are advised by the company that the first sentence of the third paragraph should read, “Following the earnings announcement, WuXi PharmaTech senior management will host a conference call at 8:00 am (Eastern) / 5:00 am (Pacific) / 8:00 pm (Beijing/Shanghai/Hong Kong) on Thursday, March 26, 2009, to discuss its 2008 fourth quarter financial results and recent business activities,” rather than, “Following the earnings announcement, WuXi PharmaTech senior management will host a conference call at 8:00 am (Eastern) / 5:00 am (Pacific) / 8:00 pm (Beijing/Shanghai/Hong Kong) on Tuesday, March 26, 2009, to discuss its 2008 fourth quarter financial results and recent business activities,” as originally issued inadvertently.
WuXi PharmaTech Schedules Fourth Quarter 2008 Earnings Release on Thursday,
SHANGHAI, China, March 12 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. , a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the fourth quarter 2008 on March 26, 2008 Shanghai time, and after the US market close on Wednesday, March 25, 2008 New York time.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )
The earnings release will be available on the investor relations section of its website at http://www.wuxiapptec.com .
Following the earnings announcement, WuXi PharmaTech senior management will host a conference call at 8:00 am (Eastern) / 5:00 am (Pacific) / 8:00 pm (Beijing/Shanghai/Hong Kong) on Thursday, March 26, 2009, to discuss its 2008 fourth quarter financial results and recent business activities. The conference call may be accessed by calling:
A telephone replay will be available two hours after the call’s completion at:
A live webcast of the conference call and replay will be available in the investor relations section of WuXi PharmaTech’s website at http://www.wuxiapptec.com .
About WuXi PharmaTech
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies with a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech’s services are designed to help its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec. For more information, please visit: http://www.wuxiapptec.com .
CONTACT: WuXi PharmaTech (Cayman) Inc., Ronald Aldridge (for investors),
Director of Investor Relations, +1-215-218-5515, or ir@wuxiapptec.com; or
Sherry Shao (for the media) of WuXi PharmaTech (Cayman) Inc.,
+86-21-5046-4002, or pr@wuxiapptec.com
Web site: http://www.wuxiapptec.com/